Poisoning caused by breathing in particles of the poisonous chemical compound beryllium oxide.
Poisoning, resulting from the inhalation of beryllium, marked by cough, chest pain, shortness of breath, and damage to lung tissue.
An environmental, chronic, inflammatory disorder of the lungs caused by the inhalation of beryllium dust. Materials that contain beryllium may be found in the aerospace, electronic, and nuclear weapon industries. The symptoms of berylliosis may not develop until several years after exposure. They include chest pain, shortness of breath on exertion, a dry cough, and, occasionally, fever and chills. Berylliosis is often treated with corticosteroids.
Poisoning by inhalation of beryllium or its compounds. This may be acute and sometimes fatal, but is more often chronic with the development of fibrosis affecting all parts of the lungs. Some workers with fluorescent light tubes and beryllium alloys may be affected.
A disease of the lungs caused by the inhalation of particles of beryllium oxide.
Beryllium poisoning, usually of the lungs. The beryllium particles cause fibrosis and granulomata at any site, whether inhaled or accidentally introduced into or under the skin.
Encounter an occupational disease triggered by the inhalation of dust or fumes containing beryllium, a metallic element prominently utilized in high-technology industries such as nuclear energy, electronics, and aerospace. Brief exposure to elevated concentrations of beryllium can result in a severe episode of pneumonitis, characterized by inflammation of the lungs. Prolonged exposure to lower concentrations over several years can lead to irreversible lung and liver damage. This occupational hazard emphasizes the importance of effective safety measures and proper ventilation systems to minimize beryllium exposure and protect workers in high-risk industries. Diligent monitoring and preventive strategies are essential to safeguard the respiratory and hepatic health of individuals working with or around beryllium.
The administration of corticosteroid drugs has shown effectiveness in mitigating lung damage caused by beryllium exposure. Treatment with these medications can help reduce inflammation and minimize the impact on lung function. However, prevention remains paramount in addressing this occupational disease. The implementation of safe working practices plays a crucial role in preventing exposure to hazardous levels of beryllium. By adhering to strict safety protocols, such as proper ventilation systems, personal protective equipment, and regular monitoring, the risk of exposure can be significantly reduced. Proactive measures and a strong commitment to workplace safety are essential in safeguarding the health and well-being of workers in industries where beryllium is utilized.